First report of vancomycin-resistant Enterococcus faecium isolated in Poland

Clinical Microbiology and Infection

Volumn 5, Issue 8, 1999, Pages 503-505

  Hryniewicz, W ^a   Szczypa, K ^a   Bronk, M ^b   Samet, A ^b   Hellmann, A ^c   Trzcinski, K ^a  

^a Sera & Vaccines Central Research Laboratory Warszawa   (Poland)

^b Public Hospital No 1   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; GLYCOPEPTIDE; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; CASE REPORT; ENTEROCOCCUS FAECIUM; FEVER; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; HUMAN CELL; IMMUNODIFFUSION; INFECTION CONTROL; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MYELOID LEUKEMIA; PHENOTYPE; PLASMID; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPING; TRANSPOSON;

EID: 0032864241     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00181.x     Document Type: Article

References (13)

1. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173-8.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B): S72-5.
3. Leclercq R. Enterococci acquire new kinds of resistance. Clin Infect Dis 1997; 24(suppl 1): S80-4
4. Leclercq R, Derlot R, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin resistance in Enterococcus faecium. N Engl J Med 1988; 319: 157-61.
5. Uttley AH, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infection. Epidemiol Infect 1989; 103: 173-81.
6. Murray B. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 1998; 4: 37-47.
7. Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997; 41: 2016-18.
8. Leclercq R, Dutka-Malen S, Duval J, et al. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36: 2005-8.
9. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by conventional test scheme. J Clin Microbiol 1989; 27: 731-4.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved Standard M7-A4. Wayne, PA: NCCLS, 1997.
11. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-7.
12. Clark N, Cooksey R, Hill B, et al. Characterisation of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37: 2311-17.
13. Barbier N, Saulnier P, Chachaty S, et al. Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 1096-9.